HRT medicine Utrogestan restricted in UK amid shortages

Pharmacists can only dispense maximum of two months' supply for every prescription as supplier struggles to meet demand

Ministers are restricting an hormone replacement therapy medicine for menopause symptoms to two-month prescriptions as the supplier struggles to meet soaring demand.

Utrogestan is expected to be in intermittent supply until late this year, according to the Department of Health and Social Care (DHSC). Officials said its manufacturer, Besins, was increasing supply but still unable to fill the gap.